Fact CheckerSign in

NCT06331130Recruiting

Mesenteric Infiltration in Ovarian Cancer

CT Detected Tumour Infiltration Patterns of the Mesentery in High Grade Ovarian Carcinoma (HGSOC) Patients, Their Role in Treatment Planning and Outcome Prediction and How Machine Learning Can be Applied to Identify Them.

Source: ClinicalTrials.gov · Last updated 12 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To evaluate if CT features at diagnosis in patients with HGSOC can be used to build an Artificial Intelligence model capable of discerning the pathological involvement of the mesentery, assessing the potential impediments for an optimal debulking surgery and predicting the development of resistance to platinum based chemotherapeutic agents.

Status (registry)
Recruiting
Study type
Observational
Enrollment
510 (estimated)
First submitted
19 Mar 2024
Start date
1 Mar 2024
Primary completion date
30 Jun 2025
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT number
NCT06331130

What you commit to

  • Study type: Observational
  • Planned participants: 510
  • From 1 Mar 2024 to the primary completion date, 30 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Non-primary diagnosis or patient subjected to neoadjuvant chemotherapy

Other illness

  • Non-serous high grade epithelial ovarian cancer (serous low grade, mucinous, clear cell carcinoma, endometrioid or non-epithelial ovarian cancer)
  • Early stage disease (I and II stage)

Other

  • CT scan not available

Who the study is looking for

  • Women with confirmed HGSOC wiht mesenteric involvment
  • Age \> 18 years
  • FIGO STAGE IIIB-IV
  • Primary diagnosis
  • Signed informed consent

Age in the registry: 18 years to - · Sex: Female

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Advanced Radiology Center
Coordinator of this site? Confirm its status
RomaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.